Strattera and Cyanocobalamin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Strattera (atomoxetine hydrochloride) and Cyanocobalamin (cyanocobalamin). Common drug interactions include memory impairment among females and gait disturbance among males.

The phase IV clinical study analyzes what interactions people have when they take Strattera and Cyanocobalamin. It is created by eHealthMe based on reports of 55 people who take the same drugs from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,323 Strattera users. Check the latest studies of Strattera.

What is Cyanocobalamin?

Cyanocobalamin has active ingredients of cyanocobalamin. It is often used in vitamin b12 deficiency. eHealthMe is studying from 14,651 Cyanocobalamin users. Check the latest studies of Cyanocobalamin.

On Jul, 12, 2026

55 people who take Strattera and Cyanocobalamin together, and have interactions are studied.

Strattera and Cyanocobalamin drug interactions.

What are the common drug interactions of Strattera and Cyanocobalamin, by gender? *:

female:

Memory impairment
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Migraine (headache)
Pain
Abdominal pain upper
Blepharospasm (any abnormal contraction or twitch of the eyelid)
Drug intolerance (drug sensitivity)
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Hypoaesthesia (reduced sense of touch or sensation)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

male:

Gait disturbance
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Death
Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
Insomnia (sleeplessness)
Nightmare (unpleasant dream)
Osteopenia (a condition where bone mineral density is lower than normal)
Parkinson's disease
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

What are the common drug interactions of Strattera and Cyanocobalamin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Drug ineffective
Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
Respiratory tract infection
Somnolence (a state of near-sleep, a strong desire for sleep)
Terminal insomnia (a sleep disorder in which there is an inability to fall asleep or to stay asleep as long as desired)

30-39:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Arthralgia (joint pain)
Emotional distress
Foot fracture
Gait disturbance
Hand fracture
Insomnia (sleeplessness)
Nightmare (unpleasant dream)
Osteopenia (a condition where bone mineral density is lower than normal)

40-49:

Memory impairment
Pain
Abdominal pain upper
Blepharospasm (any abnormal contraction or twitch of the eyelid)
Drug intolerance (drug sensitivity)
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hypoaesthesia (reduced sense of touch or sensation)
Migraine (headache)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

50-59:

n/a

60+:

Hallucination (an experience involving the perception of something not present)
Confusional state
Hallucination, visual (seeing things that aren't there)
Pain in extremity
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Skin ulcer
Constipation
Parkinson's disease
Aggression

What are the existing conditions these people have? *

Migraine (headache): 43 people, 78.18%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 9.09%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 9.09%
Hiv Infection: 3 people, 5.45%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and Cyanocobalamin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously